Left: Erik Lium, PhD, Senior Vice President of Mount Sinai Innovation Partners; and Steven J. Burakoff, MD, Director of The Tisch Cancer Institute at the Icahn School of Medicine
The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai and three other leading U.S. academic institutions recently established a pioneering research consortium to accelerate the discovery of new treatments for cancer.
In addition, Celgene Corp., a global biopharmaceutical company, paid $50 million to enter into four public-private collaboration agreements with each member of the new consortium for the option of developing and commercializing novel cancer therapeutics arising from their efforts. Read more
Members of the Mount Sinai panel included, from left, Ross L. Cagan, PhD, Director, Center for Personalized Cancer Therapeutics; Matthew Galsky, MD, Director of Genitourinary Medical Oncology; Joshua Brody, MD, Director, Lymphoma Immunotherapy Program; Steven J. Burakoff, MD, Director of The Tisch Cancer Institute; and Kenneth L. Davis, MD, President and Chief Executive Officer, Mount Sinai Health System.
At the 2016 Aspen Ideas Festival, a public gathering dedicated to the global exchange of ideas, faculty and staff from the Mount Sinai Health System provided attendees with complimentary skin cancer and heart health screenings, and participated in panel discussions on topics that included drug prices, living organ donations, gene-editing technologies, and ways to improve health care globally. The festival is presented by the Aspen Institute in partnership with The Atlantic magazine.
In a panel discussion on “Cancer Breakthroughs: The Promise of New Treatments,” specialists from the Mount Sinai Health System discussed significant advances being made in personalized vaccines and immunotherapies. The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai is involved in clinical trials that are exploring multiple approaches to immunotherapy, including intratumoral injections that are being used in combination with traditional treatments, such as surgery, radiation, and chemotherapy. Read more
Melinda Sacks receives a skin cancer screening from Morgan Rabach, MD, Clinical Instructor, Icahn School of Medicine at Mount Sinai.
When Melinda Sacks joined hundreds of other attendees at the 2014 Aspen Ideas Festival, in Aspen, Colorado, to receive a complimentary skin cancer screening by dermatologists at the Mount Sinai Health System, the clinician told her she had a suspicious spot on her face that should be checked by a specialist as soon as she returned home to Stanford, California.
Ms. Sacks says she was surprised by this because “I thought it was a birth mark.” But the small pigmented spot with a clearly defined edge was a lentigo maligna—an early form of melanoma, in which the malignant cells are confined to the tissue of origin. By catching the disease at an early stage, Ms. Sacks was able to have it removed without further complications. Read more
From left: Darren Fitzpatrick, MD; Ugo Ezenkwele, MD; Brian Radbill, MD, FACP; and Fernando C. Carnavali, MD, at the Mount Sinai Queens Ambulatory Pavilion
Against a backdrop of an evolving national health care system increasingly focused on preventive medicine, outpatient surgical procedures, and other efforts to keep people healthy and out of the hospital, Mount Sinai Queens has opened the doors to its new Ambulatory Pavilion, a $175 million facility that allows it to better serve the health needs of its community and significantly expands its medical and surgical capabilities.
Mount Sinai Queens is located in the heart of Astoria and serves the communities of Western Queens and beyond. With the addition of the Ambulatory Pavilion and continued expansion, it is positioning itself to care for more patients and extend its geographical reach throughout New York City’s largest borough. Read more
The U.S. Surgeon General, Vice Admiral Vivek H. Murthy, MD, MBA, greets patient Gloria Harrison as other patients look on.
The United States Surgeon General, Vice Admiral Vivek H. Murthy, MD, MBA, recently visited Mount Sinai Beth Israel’s Opioid Treatment Program at East 125th Street, one of the hospital’s 11 licensed addiction treatment clinics, to get a first-hand view of a facility that is successfully addressing the nationwide opioid epidemic. Mount Sinai’s model opioid treatment program was among the sites recommended to Dr. Murthy by the New York City Department of Health and Mental Hygiene. Read more
Neil Calman, MD, left, with Gail and Alfred B. Engelberg
The newly named Alfred and Gail Engelberg Department of Family Medicine and Community Health at the Icahn School of Medicine at Mount Sinai was officially unveiled during a recent plaque dedication and reception that honored Alfred B. Engelberg and his wife, Gail May Engelberg, for their generous $4 million gift.
“Mount Sinai is the only academic medical center in Manhattan to recognize that training family physicians who are capable of providing high-quality and low-cost care in urban neighborhoods is essential to the health and well-being of New York City,” said Mr. Engelberg. “We are proud to support this effort.” Read more
Lisa M. Satlin, MD, center, Pediatrician-in-Chief, Mount Sinai Health System, with Marla C. Dubinsky, MD, Chief, Pediatric Gastroenterology & Hepatology, and Jeffrey A. Stock, MD, Chief, Pediatric Urology
For the fourth consecutive year, Kravis Children’s Hospital at Mount Sinai is ranked among the nation’s top pediatric centers in seven of the ten specialties measured by U.S. News & World Report. Impressively, two of those specialties achieved a Top 25 ranking: Pulmonology and Urology, each at No. 21. U.S. News publishes the rankings annually in its “Best Children’s Hospitals” guidebook, which lists the nation’s top 50 children’s hospitals in 10 pediatric specialty areas.
“These are outstanding achievements that reflect the long-standing dedication of the Kravis Hospital’s teams of doctors, nurses, social workers, and staff in delivering the highest quality of care and improving the health outcomes of pediatric patients,” says Kenneth L. Davis, MD, President and Chief Executive Officer, Mount Sinai Health System. Read more
From left: Barbara E. Warren, PsyD; Jess Ting, MD; Matt Baney; David L. Reich, MD; Pamela Abner, MPA; and Zil Garner Goldstein, FNP
The Mount Sinai Health System recently opened the Center for Transgender Medicine and Surgery, one of the first centers of its kind in the United States to provide the transgender community with comprehensive primary, specialty, surgical, and behavioral health care services.
The Center serves a growing need to support patients in New York City through each stage of their journeys, from initial assessment and screening to hormonal therapy, surgery, and post-transition care, providing seamless access to affordable care. Gynecology, urology, endocrinology, social work, and nursing are among the specialties available at one location. Read more
Jo Carole and Ronald S. Lauder
The newly constructed Jo Carole and Ronald S. Lauder Newborn Intensive Care Unit (NICU) opened on Monday, April 4, following a complete renovation and expansion that transformed the unit into a family-centered, therapeutic space equipped with the latest technology.
The NICU is a Level III Regional Perinatal Center, which is the highest designation for complex pediatric care, and provides consultative services to other regional neonatal units. It is located on the third floor of the Klingenstein Pavilion at the Kravis Children’s Hospital at Mount Sinai. Read more
Artist’s rendering of the new ambulatory pavilion at Amsterdam Avenue and 114th Street
Renovation is set to begin this fall on a 17-floor ambulatory pavilion at Amsterdam Avenue and 114th Street that will serve as the anchor in a new master plan to transform Mount Sinai St. Luke’s outpatient care. The state-of-the-art facility will expand the hospital’s primary, preventive, and specialty care, and foster integration with all departments within the Mount Sinai Health System. Read more